Triple-negative breast cancer (TNBC) is a specific type of BC defined by the lack of expression of the estrogen receptor (ER), the progesterone receptor (PR), and human epidermal growth factor receptor type 2 (HER2), accounting for approximately 10–20% of all BC cases. This evidence concerns the gene PGR and breast cancer.